This is the company’s first clearance in its Lucent 3D line, according to an April 20 news release. The 3D-printed implant comprises a strut-and-lattice structure with a bone graft chamber access lid. The FDA clearance allows the company to stand out in the 3D-printed interbody market.
“Lucent 3D’s novel design is meant to address the challenges surgeons have shared with us of other 3D-printed interbody devices — subsidence and the amount of bone graft material available for fusion,” President and CEO Jason Blain said.
More articles on devices:
Former Laser Spine Institute leader named chief of surgery at Florida practice
Late-week spine surgeries linked to longer hospital stays, study finds
Spine spinoff, partial knee robot & more: 6 key Zimmer Biomet developments
